Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nomura Code Securities
London, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Nomura Code Securities was a specialist investment banking firm that focused exclusively on the healthcare and life sciences sectors. Formed in 2005 through Nomura's acquisition of the boutique firm Code Securities, the entity provided corporate finance, advisory, and brokerage services to biotechnology and pharmaceutical companies. The firm was highly regarded for its deep sector expertise and was involved in many of the most significant European life science IPOs and M&A transactions of its era. Nomura eventually integrated the specialist team into its broader investment banking operations and retired the Nomura Code brand in 2012.
- Industry
- Investors
Beyond the preview
Go deeper on Nomura Code Securities.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nomura Code Securities.